Literature DB >> 14682376

Clinical gene therapy for brain tumors. Liposomal delivery of anticancer molecule to glioma.

Jun Yoshida1, Masaaki Mizuno.   

Abstract

Liposomes are one of the most promising delivery systems for genes, proteins, and other biological molecules and they are expected to become a new therapeutic tool for the treatment of brain tumors, especially malignant gliomas. Until now, transfer of anticancer molecules using liposomes has been studied by a lot of investigators and it has been found to induce regression of experimental gliomas, resulting in establishing some original and effective therapies. Gene therapy using cationic liposomes is also one of them. Here we introduce the advanced medicine for brain tumors using liposomes containing some anticancer molecules (for example, gene, antibody, antisense, or magnetite), based on our basic and clinical research.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14682376     DOI: 10.1023/b:neon.0000003655.03671.fa

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  36 in total

1.  Clinical protocol. Liposomal gene therapy with the herpes simplex thymidine kinase gene/ganciclovir system for the treatment of glioblastoma multiforme.

Authors:  Jürgen Voges; Friedrich Weber; Regina Reszka; Volker Sturm; Andreas Jacobs; Wolf-Dieter Heiss; Ottmar Wiestler; Joachim Friedrich Kapp
Journal:  Hum Gene Ther       Date:  2002-03-20       Impact factor: 5.695

2.  Lipid association improves the therapeutic index of lomustine [1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea] to suppress 36B-10 tumor growth in rats.

Authors:  C R Bethune; R J Geyer; A M Spence; R J Ho
Journal:  Cancer Res       Date:  2001-05-01       Impact factor: 12.701

Review 3.  Adeno-associated viruses: an update.

Authors:  K I Berns; R A Bohenzky
Journal:  Adv Virus Res       Date:  1987       Impact factor: 9.937

4.  Heat-inducible TNF-alpha gene therapy combined with hyperthermia using magnetic nanoparticles as a novel tumor-targeted therapy.

Authors:  A Ito; M Shinkai; H Honda; T Kobayashi
Journal:  Cancer Gene Ther       Date:  2001-09       Impact factor: 5.987

5.  Nucleotide sequence and organization of the adeno-associated virus 2 genome.

Authors:  A Srivastava; E W Lusby; K I Berns
Journal:  J Virol       Date:  1983-02       Impact factor: 5.103

6.  Liposomal delivery of the herpes simplex virus thymidine kinase gene in glioma: improvement of cell sensitization to ganciclovir.

Authors:  A Zerrouqi; O Rixe; A M Ghoumari; S V Yarovoi; R Mouawad; D Khayat; C Soubrane
Journal:  Cancer Gene Ther       Date:  1996 Nov-Dec       Impact factor: 5.987

7.  Receptor-mediated delivery of an antisense gene to human brain cancer cells.

Authors:  Yun Zhang; Hwa Jeong Lee; Ruben J Boado; William M Pardridge
Journal:  J Gene Med       Date:  2002 Mar-Apr       Impact factor: 4.565

8.  Fas/APO-1 gene transfer for human malignant glioma.

Authors:  M Weller; U Malipiero; A Rensing-Ehl; P J Barr; A Fontana
Journal:  Cancer Res       Date:  1995-07-01       Impact factor: 12.701

9.  Effect of functional magnetic particles on radiofrequency capacitive heating: an in vivo study.

Authors:  Masashige Shinkai; Kousuke Ueda; Shinji Ohtsu; Hiroyuki Honda; Kenjiro Kohri; Takeshi Kobayashi
Journal:  Jpn J Cancer Res       Date:  2002-01

10.  Cationic liposome conjugation to recombinant adenoviral vector reduces viral antigenicity.

Authors:  A Natsume; M Mizuno; Y Ryuke; J Yoshida
Journal:  Jpn J Cancer Res       Date:  2000-04
View more
  10 in total

Review 1.  The status of gene therapy for brain tumors.

Authors:  Giulia Fulci; E Antonio Chiocca
Journal:  Expert Opin Biol Ther       Date:  2007-02       Impact factor: 4.388

Review 2.  Biomaterials for the central nervous system.

Authors:  Yinghui Zhong; Ravi V Bellamkonda
Journal:  J R Soc Interface       Date:  2008-09-06       Impact factor: 4.118

Review 3.  Immunological treatment of liver tumors.

Authors:  Maurizio Chiriva-Internati; Fabio Grizzi; Cynthia A Jumper; Everardo Cobos; Paul L Hermonat; Eldo E Frezza
Journal:  World J Gastroenterol       Date:  2005-11-14       Impact factor: 5.742

Review 4.  Gene Delivery in Neuro-Oncology.

Authors:  Karan Dixit; Priya Kumthekar
Journal:  Curr Oncol Rep       Date:  2017-09-02       Impact factor: 5.075

Review 5.  Drug delivery to brain tumors.

Authors:  Jaishri Blakeley
Journal:  Curr Neurol Neurosci Rep       Date:  2008-05       Impact factor: 5.081

6.  Strategies in gene therapy for glioblastoma.

Authors:  Aneta Kwiatkowska; Mohan S Nandhu; Prajna Behera; E Antonio Chiocca; Mariano S Viapiano
Journal:  Cancers (Basel)       Date:  2013-10-23       Impact factor: 6.639

Review 7.  Gene therapies for high-grade gliomas: from the bench to the bedside.

Authors:  Alice Giotta Lucifero; Sabino Luzzi; Ilaria Brambilla; Carmen Guarracino; Mario Mosconi; Thomas Foiadelli; Salvatore Savasta
Journal:  Acta Biomed       Date:  2020-06-30

Review 8.  Nanocarriers Call the Last Shot in the Treatment of Brain Cancers.

Authors:  Amin Mehrabian; Mohammad Mashreghi; Saba Dadpour; Ali Badiee; Leila Arabi; Seyedeh Hoda Alavizadeh; Seyedeh Alia Moosavian; Mahmoud Reza Jaafari
Journal:  Technol Cancer Res Treat       Date:  2022 Jan-Dec

Review 9.  Gene therapy for malignant glioma.

Authors:  Hidehiro Okura; Christian A Smith; James T Rutka
Journal:  Mol Cell Ther       Date:  2014-07-08

Review 10.  Against the Resilience of High-Grade Gliomas: The Immunotherapeutic Approach (Part I).

Authors:  Alice Giotta Lucifero; Sabino Luzzi
Journal:  Brain Sci       Date:  2021-03-18
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.